A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Clinical trial NCT01863667 · TERMINATED
Trial details
- NCT number
- NCT01863667
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-08
- Primary completion
- 2014-04-03
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.